154 related articles for article (PubMed ID: 10321960)
1. Soluble HLA in human body fluids.
Aultman D; Adamashvili I; Yaturu K; Langford M; Gelder F; Gautreaux M; Ghali GE; McDonald J
Hum Immunol; 1999 Mar; 60(3):239-44. PubMed ID: 10321960
[TBL] [Abstract][Full Text] [Related]
2. Soluble HLA in saliva of patients with autoimmune rheumatic diseases.
Adamashvili I; Pressly T; Gebel H; Milford E; Wolf R; Mancini M; Sittg K; Ghali GE; Hall V; McDonald JC
Rheumatol Int; 2002 Jun; 22(2):71-6. PubMed ID: 12070679
[TBL] [Abstract][Full Text] [Related]
3. Quantitation of soluble HLA-DR antigens in human serum and other body fluids.
Hausmann S; Claus R; Buchwald S; Köhler H; Hausmann D; Falk U; Wegener S
Beitr Infusionsther Transfusionsmed; 1994; 32():281-7. PubMed ID: 9422113
[TBL] [Abstract][Full Text] [Related]
4. Presence of detectable levels of soluble HLA-G molecules in CSF of relapsing-remitting multiple sclerosis: relationship with CSF soluble HLA-I and IL-10 concentrations and MRI findings.
Fainardi E; Rizzo R; Melchiorri L; Vaghi L; Castellazzi M; Marzola A; Govoni V; Paolino E; Tola MR; Granieri E; Baricordi OR
J Neuroimmunol; 2003 Sep; 142(1-2):149-58. PubMed ID: 14512174
[TBL] [Abstract][Full Text] [Related]
5. Soluble HLA measurement in saliva and cerebrospinal fluid in Caucasian patients with multiple sclerosis: a preliminary study.
Adamashvili I; Minagar A; Gonzalez-Toledo E; Featherston L; Kelley RE
J Neuroinflammation; 2005 Jun; 2():13. PubMed ID: 15932635
[TBL] [Abstract][Full Text] [Related]
6. Soluble HLA class I and class II molecule levels in serum and cerebrospinal fluid of multiple sclerosis patients.
Filaci G; Contini P; Brenci S; Gazzola P; Lanza L; Scudeletti M; Indiveri F; Mancardi GL; Puppo F
Hum Immunol; 1997 Apr; 54(1):54-62. PubMed ID: 9154458
[TBL] [Abstract][Full Text] [Related]
7. Intrathecal synthesis of soluble HLA-G and HLA-I molecules are reciprocally associated to clinical and MRI activity in patients with multiple sclerosis.
Fainardi E; Rizzo R; Melchiorri L; Castellazzi M; Paolino E; Tola MR; Granieri E; Baricordi OR
Mult Scler; 2006 Feb; 12(1):2-12. PubMed ID: 16459714
[TBL] [Abstract][Full Text] [Related]
8. Soluble HLA class I and class II antigens in patients with multiple sclerosis.
Ott M; Seidl C; Westhoff U; Stecker K; Seifried E; Fischer PA; Grosse-Wilde H
Tissue Antigens; 1998 Mar; 51(3):301-4. PubMed ID: 9550332
[TBL] [Abstract][Full Text] [Related]
9. Detection of soluble HLA-G molecules in plasma and amniotic fluid.
Rebmann V; Pfeiffer K; Pässler M; Ferrone S; Maier S; Weiss E; Grosse-Wilde H
Tissue Antigens; 1999 Jan; 53(1):14-22. PubMed ID: 10082427
[TBL] [Abstract][Full Text] [Related]
10. Molecular forms of soluble HLA in body fluids: potential determinants of body odor cues.
Wobst B; Zavazava N; Luszyk D; Lange K; Ussat S; Eggert F; Ferstl R; Müller-Ruchholtz W
Genetica; 1998-1999; 104(3):275-83. PubMed ID: 10386394
[TBL] [Abstract][Full Text] [Related]
11. Soluble HLA-G: purification from eukaryotic transfected cells and detection by a specific ELISA.
Fournel S; Aguerre-Girr M; Campan A; Salauze L; Berrebi A; Lone YC; Lenfant F; Le Bouteiller P
Am J Reprod Immunol; 1999 Jul; 42(1):22-9. PubMed ID: 10429763
[TBL] [Abstract][Full Text] [Related]
12. CSF levels of soluble HLA-G and Fas molecules are inversely associated to MRI evidence of disease activity in patients with relapsing-remitting multiple sclerosis.
Fainardi E; Rizzo R; Melchiorri L; Stignani M; Castellazzi M; Tamborino C; Paolino E; Tola MR; Granieri E; Baricordi OR
Mult Scler; 2008 May; 14(4):446-54. PubMed ID: 18208868
[TBL] [Abstract][Full Text] [Related]
13. [Histocompatibility HLA system of man. Considerations in the light of current concepts. V. sHLA-I in patient's body fluids].
Kedzierska A; Turowski G
Przegl Lek; 2001; 58(9):868-72. PubMed ID: 11868250
[TBL] [Abstract][Full Text] [Related]
14. Soluble MHC class I molecules in human body fluids.
Zavazava N; Wobst B; Ferstl R; Müller-Ruchholtz W
J Clin Lab Anal; 1994; 8(6):432-6. PubMed ID: 7869184
[TBL] [Abstract][Full Text] [Related]
15. Characterization of soluble HLA molecules in sweat and quantitative HLA differences in serum of healthy individuals.
Zavazava N; Westphal E; Müller-Ruchholtz W
J Immunogenet; 1990 Dec; 17(6):387-94. PubMed ID: 2096183
[TBL] [Abstract][Full Text] [Related]
16. Influence of anticoagulants on the level of soluble HLA class I and class II antigens measured in blood samples.
Hausmann S; Claus R; Falk U; Wegener S
J Immunoassay; 1996 Aug; 17(3):257-75. PubMed ID: 8842984
[TBL] [Abstract][Full Text] [Related]
17. Soluble HLA class I molecules/CD8 ligation trigger apoptosis of CD8+ cells by Fas/Fas-ligand interaction.
Puppo F; Contini P; Ghio M; Indiveri F
ScientificWorldJournal; 2002 Feb; 2():421-3. PubMed ID: 12806026
[TBL] [Abstract][Full Text] [Related]
18. Saliva soluble HLA as a potential marker of response to interferon-beta 1a in multiple sclerosis: a preliminary study.
Minagar A; Adamashvili I; Kelley RE; Gonzalez-Toledo E; McLarty J; Smith SJ
J Neuroinflammation; 2007 Jul; 4():16. PubMed ID: 17601341
[TBL] [Abstract][Full Text] [Related]
19. Soluble HLA-I (s-HLA-I) synthesis in systemic lupus erythematosus.
Adamashvili I; Wolf R; Aultman D; Milford EL; Jaffe S; Hall V; Pressly T; Minagar A; Kelley R
Rheumatol Int; 2003 Nov; 23(6):294-300. PubMed ID: 12879264
[TBL] [Abstract][Full Text] [Related]
20. Report of the Wet Workshop for Quantification of Soluble HLA-G in Essen, 2004.
Rebmann V; Lemaoult J; Rouas-Freiss N; Carosella ED; Grosse-Wilde H
Hum Immunol; 2005 Aug; 66(8):853-63. PubMed ID: 16216668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
